BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

408 related articles for article (PubMed ID: 26872061)

  • 1. Cerebrospinal fluid chitinase-3-like 2 and chitotriosidase are potential prognostic biomarkers in early multiple sclerosis.
    Møllgaard M; Degn M; Sellebjerg F; Frederiksen JL; Modvig S
    Eur J Neurol; 2016 May; 23(5):898-905. PubMed ID: 26872061
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cerebrospinal fluid levels of chitinase 3-like 1 and neurofilament light chain predict multiple sclerosis development and disability after optic neuritis.
    Modvig S; Degn M; Roed H; Sørensen TL; Larsson HB; Langkilde AR; Frederiksen JL; Sellebjerg F
    Mult Scler; 2015 Dec; 21(14):1761-70. PubMed ID: 25698172
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CSF chitinase proteins in amyotrophic lateral sclerosis.
    Thompson AG; Gray E; Bampton A; Raciborska D; Talbot K; Turner MR
    J Neurol Neurosurg Psychiatry; 2019 Nov; 90(11):1215-1220. PubMed ID: 31123140
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chitinase 3-like proteins as diagnostic and prognostic biomarkers of multiple sclerosis.
    Hinsinger G; Galéotti N; Nabholz N; Urbach S; Rigau V; Demattei C; Lehmann S; Camu W; Labauge P; Castelnovo G; Brassat D; Loussouarn D; Salou M; Laplaud D; Casez O; Bockaert J; Marin P; Thouvenot E
    Mult Scler; 2015 Sep; 21(10):1251-61. PubMed ID: 25698171
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chitinase 3-like 1: prognostic biomarker in clinically isolated syndromes.
    Cantó E; Tintoré M; Villar LM; Costa C; Nurtdinov R; Álvarez-Cermeño JC; Arrambide G; Reverter F; Deisenhammer F; Hegen H; Khademi M; Olsson T; Tumani H; Rodríguez-Martín E; Piehl F; Bartos A; Zimova D; Kotoucova J; Kuhle J; Kappos L; García-Merino JA; Sánchez AJ; Saiz A; Blanco Y; Hintzen R; Jafari N; Brassat D; Lauda F; Roesler R; Rejdak K; Papuc E; de Andrés C; Rauch S; Khalil M; Enzinger C; Galimberti D; Scarpini E; Teunissen C; Sánchez A; Rovira A; Montalban X; Comabella M
    Brain; 2015 Apr; 138(Pt 4):918-31. PubMed ID: 25688078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cerebrospinal fluid macrophage biomarkers in amyotrophic lateral sclerosis.
    Thompson AG; Gray E; Thézénas ML; Charles PD; Evetts S; Hu MT; Talbot K; Fischer R; Kessler BM; Turner MR
    Ann Neurol; 2018 Feb; 83(2):258-268. PubMed ID: 29331073
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chitinase effects on immune cell response in neuromyelitis optica and multiple sclerosis.
    Correale J; Fiol M
    Mult Scler; 2011 May; 17(5):521-31. PubMed ID: 21159721
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship between cerebrospinal fluid biomarkers for inflammation, demyelination and neurodegeneration in acute optic neuritis.
    Modvig S; Degn M; Horwitz H; Cramer SP; Larsson HB; Wanscher B; Sellebjerg F; Frederiksen JL
    PLoS One; 2013; 8(10):e77163. PubMed ID: 24116216
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical usefulness of prognostic biomarkers in optic neuritis.
    Tejeda-Velarde A; Costa-Frossard L; Sainz de la Maza S; Carrasco Á; Espiño M; Picón C; Toboso I; Walo PE; Lourido D; Muriel A; Álvarez-Cermeño JC; Villar LM
    Eur J Neurol; 2018 Apr; 25(4):614-618. PubMed ID: 29272057
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CSF Chitinase 3-Like 2 Is Associated With Long-term Disability Progression in Patients With Progressive Multiple Sclerosis.
    Comabella M; Sastre-Garriga J; Borras E; Villar LM; Saiz A; Martínez-Yélamos S; García-Merino JA; Pinteac R; Fissolo N; Sánchez López AJ; Costa-Frossard L; Blanco Y; Llufriu S; Vidal-Jordana A; Sabidó E; Montalban X
    Neurol Neuroimmunol Neuroinflamm; 2021 Nov; 8(6):. PubMed ID: 34497102
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determination of chitinase 3-like 1 in cerebrospinal fluid in multiple sclerosis and other neurological diseases.
    Kušnierová P; Zeman D; Hradílek P; Zapletalová O; Stejskal D
    PLoS One; 2020; 15(5):e0233519. PubMed ID: 32437412
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CSF chitinase 3-like-1 association with disability of primary progressive MS.
    Pérez-Miralles F; Prefasi D; García-Merino A; Gascón-Giménez F; Medrano N; Castillo-Villalba J; Cubas L; Alcalá C; Gil-Perotín S; Gómez-Ballesteros R; Maurino J; Álvarez-García E; Casanova B
    Neurol Neuroimmunol Neuroinflamm; 2020 Sep; 7(5):. PubMed ID: 32611760
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cerebrospinal fluid chitinase 3-like 1 levels are associated with conversion to multiple sclerosis.
    Comabella M; Fernández M; Martin R; Rivera-Vallvé S; Borrás E; Chiva C; Julià E; Rovira A; Cantó E; Alvarez-Cermeño JC; Villar LM; Tintoré M; Montalban X
    Brain; 2010 Apr; 133(Pt 4):1082-93. PubMed ID: 20237129
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chitinases as a potential diagnostic and prognostic biomarker for amyotrophic lateral sclerosis: a systematic review and meta-analysis.
    Xu A; Luo Y; Tang Y; Yang F; Gao X; Qiao G; Zhu X; Zhou J
    Neurol Sci; 2024 Jun; 45(6):2489-2503. PubMed ID: 38194198
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurofilament light chain and oligoclonal bands are prognostic biomarkers in radiologically isolated syndrome.
    Matute-Blanch C; Villar LM; Álvarez-Cermeño JC; Rejdak K; Evdoshenko E; Makshakov G; Nazarov V; Lapin S; Midaglia L; Vidal-Jordana A; Drulovic J; García-Merino A; Sánchez-López AJ; Havrdova E; Saiz A; Llufriu S; Alvarez-Lafuente R; Schroeder I; Zettl UK; Galimberti D; Ramió-Torrentà L; Robles R; Quintana E; Hegen H; Deisenhammer F; Río J; Tintoré M; Sánchez A; Montalban X; Comabella M
    Brain; 2018 Apr; 141(4):1085-1093. PubMed ID: 29452342
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cerebrospinal fluid neurofilament light chain levels predict visual outcome after optic neuritis.
    Modvig S; Degn M; Sander B; Horwitz H; Wanscher B; Sellebjerg F; Frederiksen JL
    Mult Scler; 2016 Apr; 22(5):590-8. PubMed ID: 26283696
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CSF chitinases before and after symptom onset in amyotrophic lateral sclerosis.
    Gray E; Thompson AG; Wuu J; Pelt J; Talbot K; Benatar M; Turner MR
    Ann Clin Transl Neurol; 2020 Aug; 7(8):1296-1306. PubMed ID: 32666680
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CHIT1 at Diagnosis Reflects Long-Term Multiple Sclerosis Disease Activity.
    Oldoni E; Smets I; Mallants K; Vandebergh M; Van Horebeek L; Poesen K; Dupont P; Dubois B; Goris A
    Ann Neurol; 2020 Apr; 87(4):633-645. PubMed ID: 31997416
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cerebrospinal fluid biomarkers for predicting development of multiple sclerosis in acute optic neuritis: a population-based prospective cohort study.
    Olesen MN; Soelberg K; Debrabant B; Nilsson AC; Lillevang ST; Grauslund J; Brandslund I; Madsen JS; Paul F; Smith TJ; Jarius S; Asgari N
    J Neuroinflammation; 2019 Mar; 16(1):59. PubMed ID: 30857557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oligoclonal band versus chitinase-3-like protein-1 in CSF of newly diagnosed relapsing remitting multiple sclerosis.
    Samaha DY; Zeitoun YA; Fouad NT; Abdel Aziz AA; Saad MA
    Egypt J Immunol; 2023 Jan; 30(1):42-48. PubMed ID: 36591957
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.